211 related articles for article (PubMed ID: 9568175)
41. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.
Borchers H; Meyers FJ; Gumerlock PH; Stewart SL; deVere White RW
J Urol; 1996 Jun; 155(6):2080-4. PubMed ID: 8618340
[TBL] [Abstract][Full Text] [Related]
42. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
43. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.
Furumoto K; Arii S; Mori A; Furuyama H; Gorrin Rivas MJ; Nakao T; Isobe N; Murata T; Takahashi C; Noda M; Imamura M
Hepatology; 2001 Jan; 33(1):189-95. PubMed ID: 11124835
[TBL] [Abstract][Full Text] [Related]
44. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
45. High levels of nm23 expression are related to cell proliferation in human prostate cancer.
Igawa M; Rukstalis DB; Tanabe T; Chodak GW
Cancer Res; 1994 Mar; 54(5):1313-8. PubMed ID: 8118821
[TBL] [Abstract][Full Text] [Related]
46. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
[TBL] [Abstract][Full Text] [Related]
47. Nm23-H1 expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma.
Shimada M; Taguchi K; Hasegawa H; Gion T; Shirabe K; Tsuneyoshi M; Sugimachi K
Liver; 1998 Oct; 18(5):337-42. PubMed ID: 9831363
[TBL] [Abstract][Full Text] [Related]
48. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.
Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS
Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356
[TBL] [Abstract][Full Text] [Related]
49. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.
Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I
Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
51. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
Kuo JY; Chang KM; Chen KK; Chang LS
Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
[TBL] [Abstract][Full Text] [Related]
52. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
Leone A; Flatow U; VanHoutte K; Steeg PS
Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
[TBL] [Abstract][Full Text] [Related]
53. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
[TBL] [Abstract][Full Text] [Related]
54. Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma.
Huang GW; Mo WN; Kuang GQ; Nong HT; Wei MY; Sunagawa M; Kosugi T
Laryngoscope; 2001 Aug; 111(8):1465-71. PubMed ID: 11568585
[TBL] [Abstract][Full Text] [Related]
55. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma.
Schneider J; Pollán M; Jiménez E; Marenbach K; Martínez N; Volm M; Marx D; Meden H
Br J Cancer; 2000 May; 82(10):1662-70. PubMed ID: 10817501
[TBL] [Abstract][Full Text] [Related]
56. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
[TBL] [Abstract][Full Text] [Related]
57. nm23-H1 protein expression in anal canal carcinoma: does it correlate with prognosis?
Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; Limiti MR; Ghini C; Vecchione A
J Surg Oncol; 2000 Jun; 74(2):163-6. PubMed ID: 10914829
[TBL] [Abstract][Full Text] [Related]
58. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
Urakami S; Igawa M; Shirakawa H; Shiina H; Kawanishi M
J Urol; 1997 May; 157(5):1928-31. PubMed ID: 9112565
[TBL] [Abstract][Full Text] [Related]
59. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer.
Qian M; Feng Y; Xu L; Zheng S; Zhou X
Chin Med J (Engl); 1997 Feb; 110(2):142-4. PubMed ID: 9594287
[TBL] [Abstract][Full Text] [Related]
60. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.
Boix L; Bruix J; Campo E; Sole M; Castells A; Fuster J; Rivera F; Cardesa A; Rodes J
Gastroenterology; 1994 Aug; 107(2):486-91. PubMed ID: 8039626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]